<code id='464EAD7444'></code><style id='464EAD7444'></style>
    • <acronym id='464EAD7444'></acronym>
      <center id='464EAD7444'><center id='464EAD7444'><tfoot id='464EAD7444'></tfoot></center><abbr id='464EAD7444'><dir id='464EAD7444'><tfoot id='464EAD7444'></tfoot><noframes id='464EAD7444'>

    • <optgroup id='464EAD7444'><strike id='464EAD7444'><sup id='464EAD7444'></sup></strike><code id='464EAD7444'></code></optgroup>
        1. <b id='464EAD7444'><label id='464EAD7444'><select id='464EAD7444'><dt id='464EAD7444'><span id='464EAD7444'></span></dt></select></label></b><u id='464EAD7444'></u>
          <i id='464EAD7444'><strike id='464EAD7444'><tt id='464EAD7444'><pre id='464EAD7444'></pre></tt></strike></i>

          Wikipedia

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          With competition flaring, obesity drug hits goal in liver disease study
          With competition flaring, obesity drug hits goal in liver disease study

          AdobeLONDON—AdrugindevelopmentasaweightlosstreatmentsucceededinaPhase2studyinaseriouslivercondition,

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Annovis Bio delivers candor, but not confidence, on Parkinson’s study

          MollyFerguson/STATAnnovisBiohadmybiotechbull%^&!meterrunningredafteritmadealatechangetothedesign